Logo image of SUZ

SUZANO SA - SPON ADR (SUZ) Stock Fundamental Analysis

USA - NYSE:SUZ - US86959K1051 - ADR

9.21 USD
-0.03 (-0.32%)
Last: 9/29/2025, 12:49:47 PM
Fundamental Rating

7

SUZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 9 industry peers in the Paper & Forest Products industry. SUZ scores excellent on profitability, but there are some minor concerns on its financial health. SUZ scores decently on growth, while it is valued quite cheap. This could make an interesting combination. SUZ also has an excellent dividend rating. These ratings would make SUZ suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SUZ had positive earnings in the past year.
SUZ had a positive operating cash flow in the past year.
In multiple years SUZ reported negative net income over the last 5 years.
Each year in the past 5 years SUZ had a positive operating cash flow.
SUZ Yearly Net Income VS EBIT VS OCF VS FCFSUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

SUZ has a better Return On Assets (4.91%) than 66.67% of its industry peers.
SUZ has a Return On Equity of 18.14%. This is in the better half of the industry: SUZ outperforms 77.78% of its industry peers.
The Return On Invested Capital of SUZ (7.05%) is better than 77.78% of its industry peers.
SUZ had an Average Return On Invested Capital over the past 3 years of 9.38%. This is above the industry average of 5.72%.
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROIC 7.05%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
SUZ Yearly ROA, ROE, ROICSUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

SUZ's Profit Margin of 15.26% is amongst the best of the industry. SUZ outperforms 100.00% of its industry peers.
SUZ has a Operating Margin of 25.74%. This is amongst the best in the industry. SUZ outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of SUZ has grown nicely.
SUZ has a better Gross Margin (37.73%) than 100.00% of its industry peers.
SUZ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
SUZ Yearly Profit, Operating, Gross MarginsSUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SUZ is creating some value.
Compared to 1 year ago, SUZ has less shares outstanding
The number of shares outstanding for SUZ has been reduced compared to 5 years ago.
The debt/assets ratio for SUZ is higher compared to a year ago.
SUZ Yearly Shares OutstandingSUZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SUZ Yearly Total Debt VS Total AssetsSUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that SUZ is in the distress zone and has some risk of bankruptcy.
SUZ has a worse Altman-Z score (1.23) than 66.67% of its industry peers.
The Debt to FCF ratio of SUZ is 17.09, which is on the high side as it means it would take SUZ, 17.09 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SUZ (17.09) is comparable to the rest of the industry.
SUZ has a Debt/Equity ratio of 2.20. This is a high value indicating a heavy dependency on external financing.
SUZ has a worse Debt to Equity ratio (2.20) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Altman-Z 1.23
ROIC/WACC1.06
WACC6.63%
SUZ Yearly LT Debt VS Equity VS FCFSUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

SUZ has a Current Ratio of 3.16. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
SUZ has a better Current ratio (3.16) than 100.00% of its industry peers.
SUZ has a Quick Ratio of 2.48. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SUZ (2.48) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.48
SUZ Yearly Current Assets VS Current LiabilitesSUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 3877.50% over the past year.
SUZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.38%.
SUZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.75% yearly.
EPS 1Y (TTM)3877.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236.73%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%15.68%

3.2 Future

The Earnings Per Share is expected to grow by 52.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, SUZ will show a quite strong growth in Revenue. The Revenue will grow by 15.19% on average per year.
EPS Next Y265.49%
EPS Next 2Y79.89%
EPS Next 3Y52.44%
EPS Next 5YN/A
Revenue Next Year9.93%
Revenue Next 2Y12.89%
Revenue Next 3Y11.41%
Revenue Next 5Y15.19%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SUZ Yearly Revenue VS EstimatesSUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
SUZ Yearly EPS VS EstimatesSUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.74 indicates a rather cheap valuation of SUZ.
SUZ's Price/Earnings ratio is rather cheap when compared to the industry. SUZ is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of SUZ to the average of the S&P500 Index (27.54), we can say SUZ is valued rather cheaply.
A Price/Forward Earnings ratio of 7.20 indicates a rather cheap valuation of SUZ.
88.89% of the companies in the same industry are more expensive than SUZ, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.05. SUZ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.74
Fwd PE 7.2
SUZ Price Earnings VS Forward Price EarningsSUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SUZ is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SUZ is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.6
EV/EBITDA 5.55
SUZ Per share dataSUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

SUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SUZ has a very decent profitability rating, which may justify a higher PE ratio.
SUZ's earnings are expected to grow with 52.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y79.89%
EPS Next 3Y52.44%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.16%, SUZ is a good candidate for dividend investing.
SUZ's Dividend Yield is a higher than the industry average which is at 4.53.
Compared to an average S&P500 Dividend Yield of 2.41, SUZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.16%

5.2 History

On average, the dividend of SUZ grows each year by 20.94%, which is quite nice.
SUZ has paid a dividend for at least 10 years, which is a reliable track record.
SUZ has decreased its dividend recently.
Dividend Growth(5Y)20.94%
Div Incr Years1
Div Non Decr Years1
SUZ Yearly Dividends per shareSUZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

32.13% of the earnings are spent on dividend by SUZ. This is a low number and sustainable payout ratio.
SUZ's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.13%
EPS Next 2Y79.89%
EPS Next 3Y52.44%
SUZ Yearly Income VS Free CF VS DividendSUZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B
SUZ Dividend Payout.SUZ Dividend Payout, showing the Payout Ratio.SUZ Dividend Payout.PayoutRetained Earnings

SUZANO SA - SPON ADR

NYSE:SUZ (9/29/2025, 12:49:47 PM)

9.21

-0.03 (-0.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners27.27%
Inst Owner Change4.98%
Ins Owners15.51%
Ins Owner ChangeN/A
Market Cap11.38B
Analysts82.73
Price Target14.25 (54.72%)
Short Float %0.49%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield 4.16%
Yearly Dividend0.24
Dividend Growth(5Y)20.94%
DP32.13%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.78%
Min EPS beat(2)12.88%
Max EPS beat(2)196.69%
EPS beat(4)3
Avg EPS beat(4)-81.54%
Min EPS beat(4)-569.87%
Max EPS beat(4)196.69%
EPS beat(8)6
Avg EPS beat(8)-62.1%
EPS beat(12)9
Avg EPS beat(12)-31.22%
EPS beat(16)12
Avg EPS beat(16)-21.71%
Revenue beat(2)1
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)0.92%
Revenue beat(4)2
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-6.63%
Max Revenue beat(4)6.32%
Revenue beat(8)5
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)-0.52%
Revenue beat(16)10
Avg Revenue beat(16)-0.12%
PT rev (1m)2.14%
PT rev (3m)4.6%
EPS NQ rev (1m)-16.77%
EPS NQ rev (3m)-55.97%
EPS NY rev (1m)11.81%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)-2.66%
Revenue NQ rev (3m)-7.78%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-7%
Valuation
Industry RankSector Rank
PE 7.74
Fwd PE 7.2
P/S 1.19
P/FCF 10.6
P/OCF 3.01
P/B 1.41
P/tB 2.05
EV/EBITDA 5.55
EPS(TTM)1.19
EY12.92%
EPS(NY)1.28
Fwd EY13.88%
FCF(TTM)0.87
FCFY9.44%
OCF(TTM)3.06
OCFY33.18%
SpS7.75
BVpS6.51
TBVpS4.49
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROCE 8.99%
ROIC 7.05%
ROICexc 8.18%
ROICexgc 9.16%
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
FCFM 11.22%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
ROICexc(3y)11.06%
ROICexc(5y)11.2%
ROICexgc(3y)12.82%
ROICexgc(5y)13.35%
ROCE(3y)11.96%
ROCE(5y)11.98%
ROICexcg growth 3Y-17.29%
ROICexcg growth 5Y26.8%
ROICexc growth 3Y-14.86%
ROICexc growth 5Y30.34%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Debt/EBITDA 4
Cap/Depr 138.59%
Cap/Sales 28.23%
Interest Coverage 2.36
Cash Conversion 85.57%
Profit Quality 73.57%
Current Ratio 3.16
Quick Ratio 2.48
Altman-Z 1.23
F-Score7
WACC6.63%
ROIC/WACC1.06
Cap/Depr(3y)212.09%
Cap/Depr(5y)160.32%
Cap/Sales(3y)37.3%
Cap/Sales(5y)28.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3877.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236.73%
EPS Next Y265.49%
EPS Next 2Y79.89%
EPS Next 3Y52.44%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%15.68%
Revenue Next Year9.93%
Revenue Next 2Y12.89%
Revenue Next 3Y11.41%
Revenue Next 5Y15.19%
EBIT growth 1Y18.91%
EBIT growth 3Y-4.42%
EBIT growth 5Y42.3%
EBIT Next Year55.36%
EBIT Next 3Y26.69%
EBIT Next 5Y20.91%
FCF growth 1Y71.41%
FCF growth 3Y-30.27%
FCF growth 5Y9.93%
OCF growth 1Y-7.35%
OCF growth 3Y5.32%
OCF growth 5Y22.15%